Use of Erythropoiesis Stimulating Agents (ESAs) in Patients Receiving Myelosuppressive Chemotherapy in Europe and the UK (20190404)

First published 22/11/2022

Last updated 15/10/2024

EU PAS number:

EUPAS49757

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

Protocol-Published Amendment darbepoetin alfa 20190404 4 redacted

English (742.8 KB - PDF)View document

Updated protocol

Protocol-Published Amendment darbepoetin alfa 20190404 6.pdf

First published: 26/08/2024

English (791.03 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents